Fundraising Fox

Sydnexis

Del Mar, US · Founded 2014 · Delaware corporation · 3 known investors

sydnexis.com ↗
Biotechin /sydnexis

Founders & leadership

MJ
Mary Jaqueline JohnsonExecutive Officer
ZS
Zach ScheinerDirector
PJ
Patrick JohnsonExecutive Officer, Promoter
PS
Perry SternbergExecutive Officer, Director, Promoter
JK
Jeffry K. WeinhuffDirector
TS
Tyler StowaterDirector
JB
Juliet BakkerDirector
RL
Richard LindstromDirector
MJ
Mary Jacqueline JohnsonExecutive Officer
KJ
Kevin JohnsonDirector
GO
Greg OstrowExecutive Officer, Director
KW
Kenneth WidderExecutive Officer, Director

Investors · 3

Longitude CapitalMenlo Park · $10M – $30M
RA CapitalBoston
Visionary VenturesNewport Beach · $5M – $15M

Reported raises · per SEC filings

Form D private placements
▶$20MraisedApr 2025 · 23 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary Jaqueline JohnsonExecutive Officer
  • Zach ScheinerDirector
  • Patrick JohnsonExecutive Officer, Promoter
  • Perry SternbergExecutive Officer, Director, Promoter
  • Jeffry K. WeinhuffDirector
  • Tyler StowaterDirector
  • Juliet BakkerDirector
  • Richard LindstromDirector
Offering amount
$20M
Amount sold
$20M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$999.8KraisedMay 2024 · 30 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard LindstromDirector
  • Zach ScheinerDirector
  • Juliet BakkerDirector
  • Mary Jaqueline JohnsonExecutive Officer
  • Patrick JohnsonExecutive Officer, Promoter
  • Jeffry K. WeinhuffDirector
  • Tyler StowaterDirector
Offering amount
$8.5M
Amount sold
$999.8K
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.8MraisedAug 2021 · 26 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Tyler StowaterDirector
  • Kenneth WidderExecutive Officer, Director, Promoter
  • Richard LindstromDirector
  • Patrick JohnsonExecutive Officer, Promoter
  • Mary Jacqueline JohnsonExecutive Officer
  • Zachary ScheinerDirector
  • Greg GrunbergDirector
  • Jeffry K. WeinhuffDirector
Offering amount
$45.8M
Amount sold
$45.8M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedOct 2017 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary Jacqueline JohnsonExecutive Officer
  • Kevin JohnsonDirector
  • Greg OstrowExecutive Officer, Director
  • Zachary ScheinerDirector
  • Kenneth WidderExecutive Officer, Director
Offering amount
$35M
Amount sold
$5.5M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.